At a glance
ClinicalIndex Comparison RecordN/ACompleted· 50 enrolled
Drug / intervention
Gana Xdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Study for the Effectiveness of Use of an Injectable Medical Device GANA X® in the Treatment of Buttocks Volume Depression
In Brief
A clinical study evaluating Gana X for Buttocks Volume Loss. Completed, enrolled 50 participants across 1 site.
Detailed Summary
The purpose of this study is to assess the effectiveness and safety of Gana X, a Poly L-lactic acid filler for the aesthetic treatment of buttocks.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsButtocks Volume Loss
CountriesFrance
CollaboratorsEurofins Dermscan Pharmascan
Timeline
N/ACompletedFinished
2023202420252026
Enrollment StartMay 2022
First PostedMay 2022
Primary CompletionApr 2023
Study CompletionNov 2024
TodayJul 2026
First PostedMay 5, 2022
Enrollment StartMay 2, 2022
Primary CompletionApr 25, 2023
Study CompletionNov 4, 2024
TodayJul 2, 2026
Enrollment to primary: 12 monthsPosted 4.2 years ago
Interventions
Gana Xdevice
Injection in the deep dermis and subcutaneous layer of the buttocks on D0 (initial injection) and 1 month and a half after initial injection if necessary (optional touch-up).